T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.94B |
| 2 |
Broadcom
AVGO
|
+$2.74B |
| 3 |
Microsoft
MSFT
|
+$2.33B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.47B |
| 5 |
GE Aerospace
GE
|
+$1.27B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.42B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$2.44B |
| 3 |
Apple
AAPL
|
+$2.42B |
| 4 |
FISV
Fiserv Inc
FISV
|
+$2.3B |
| 5 |
Eli Lilly
LLY
|
+$1.78B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.73% |
| 2 | Financials | 12.11% |
| 3 | Healthcare | 10.97% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Monte Rosa Therapeutics
GLUE
$1.33B
| $28.5M | ﹤0.01% |
6,325,658
-318,478
| -5% | -$1.42M |
|
877
Legend Biotech
LEGN
$3.92B
| $28.4M | ﹤0.01% |
800,220
-5,929,559
| -88% | -$192M |
|
878
SLM Corp
SLM
$5.24B
| $28.4M | ﹤0.01% |
865,031
+45,725
| +6% | +$1.4M |
|
879
Murphy USA
MUSA
$10.5B
| $28.3M | ﹤0.01% |
69,465
-124,536
| -64% | -$56.6M |
|
880
Hims & Hers Health
HIMS
$6.6B
| $28.1M | ﹤0.01% |
563,877
-84,895
| -13% | -$3.84M |
|
881
Oric Pharmaceuticals
ORIC
$1.43B
| $28M | ﹤0.01% |
2,762,915
+1,430,055
| +107% | +$9.6M |
|
882
Immunome
IMNM
$3.06B
| $27.7M | ﹤0.01% |
2,982,080
-87,527
| -3% | -$718K |
|
883
International Flavors & Fragrances
IFF
$21.4B
| $27.7M | ﹤0.01% |
376,082
-900,100
| -71% | -$68M |
|
884
Service Corp International
SCI
$11.5B
| $27.6M | ﹤0.01% |
339,658
-45,970
| -12% | -$3.59M |
|
885
Estee Lauder
EL
$31.4B
| $27.5M | ﹤0.01% |
340,661
-440,680
| -56% | -$28.3M |
|
886
Core & Main
CNM
$8.58B
| $27.5M | ﹤0.01% |
456,016
+32,370
| +8% | +$1.73M |
|
887
Trimble
TRMB
$13.3B
| $27.4M | ﹤0.01% |
361,135
-1,196
| -0.3% | -$80.3K |
|
888
Dow Inc
DOW
$22.4B
| $27.1M | ﹤0.01% |
1,024,927
+4,404
| +0.4% | +$128K |
|
889
Haemonetics
HAE
$4.14B
| $27M | ﹤0.01% |
361,442
+4,260
| +1% | +$282K |
|
890
Invitation Homes
INVH
$18B
| $26.9M | ﹤0.01% |
819,529
-5,527
| -0.7% | -$186K |
|
891
Addus HomeCare
ADUS
$2.17B
| $26.4M | ﹤0.01% |
229,265
+2,207
| +1% | +$238K |
|
892
Tapestry
TPR
$26B
| $26.3M | ﹤0.01% |
299,185
-116,034
| -28% | -$8.79M |
|
893
West Pharmaceutical
WST
$24.6B
| $25.7M | ﹤0.01% |
117,629
-37,122
| -24% | -$7.94M |
|
894
Vital Farms
VITL
$470M
| $25.6M | ﹤0.01% |
665,530
+3,472
| +0.5% | +$117K |
|
895
Braze
BRZE
$3.28B
| $25.5M | ﹤0.01% |
906,830
-172,906
| -16% | -$5.47M |
|
|
SF
896
Stifel
SF
$12.9B
| $25.4M | ﹤0.01% |
367,364
-230,586
| -39% | -$14.2M |
|
897
Travel + Leisure Co
TNL
$4.62B
| $25.4M | ﹤0.01% |
491,903
+9,668
| +2% | +$454K |
|
898
Halliburton
HAL
$28.7B
| $25.3M | ﹤0.01% |
1,241,395
-231,417
| -16% | -$4.85M |
|
899
Mid-America Apartment Communities
MAA
$15.5B
| $25.2M | ﹤0.01% |
170,330
+1,551
| +0.9% | +$242K |
|
900
CACI
CACI
$14.7B
| $25.2M | ﹤0.01% |
52,832
+107
| +0.2% | +$47.4K |
|
Similar funds
T. Rowe Price Associates's Q2 2025 Portfolio in Review
As of Q2 2025, T. Rowe Price Associates held 3,193 positions worth $883B, up 8.8% from $812B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
T. Rowe Price Associates's Q2 2025 filing shows 153 new, 2,010 increased, 803 reduced and 136 closed positions. Its largest new stake was Ralliant Corp: 4,667,638 shares worth $226M. The largest sale was Amazon, an estimated $3.42B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 30% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q2 2025 buy was Ralliant Corp: 4,667,638 shares worth $226M.
- T. Rowe Price Associates added most to NVIDIA in Q2 2025, an estimated $3.94B increase.
- T. Rowe Price Associates's biggest Q2 2025 reduction was Amazon, cutting an estimated $3.42B.
- T. Rowe Price Associates fully exited US Steel in Q2 2025, selling an estimated $146M.
- T. Rowe Price Associates's ten largest holdings make up 36% of its $883B portfolio in Q2 2025.
- T. Rowe Price Associates opened 153 new positions and closed 136 in Q2 2025.
- T. Rowe Price Associates's portfolio value rose 8.8% quarter-over-quarter to $883B.
Based on T. Rowe Price Associates's 13F filing for Q2 2025, filed 14 Aug 2025.